A Phase 2 Study of IW-3300 for the Treatment of Bladder Pain in Subjects With Interstitial Cystitis/Bladder Pain Syndrome

Clinical trial NCT05740007 · TERMINATED

Trial details

NCT number: NCT05740007
Sponsor: Ironwood Pharmaceuticals, Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Interstitial Cystitis Bladder Pain Syndrome

Start date: 2023-03-28
Primary completion: 2025-01-23
Enrollment: 98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.